Bayesian Capital Management, LP Spring Works Therapeutics, Inc. Transaction History

Bayesian Capital Management, LP

  • $788 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$32.04 - $42.76 $339,624 - $453,256
10,600 Added 120.26%
19,414 $622,000
Q2 2024

Aug 14, 2024
BUY
$36.06 - $47.62 $317,832 - $419,722
8,814 New
8,814 $332,000
Q4 2023

Feb 14, 2024
BUY
$18.94 - $37.24 $121,178 - $238,261
6,398 New
6,398 $233,000

Others Institutions Holding SWTX

# of Institutions
235
Shares Held
67.2M
Call Options Held
260K
Put Options Held
316K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.95B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email